Contract Liabilities
Gilead Sciences Contract Liabilities decreased by 3.4% to $56.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 17.6%, from $68.00M to $56.00M. Over 4 years (FY 2020 to FY 2024), Contract Liabilities shows a downward trend with a -12.1% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests strong future revenue visibility and customer demand, while a decrease may indicate faster fulfillment or slowing sales.
Detailed definition
This represents the obligation to transfer goods or services to a customer for which the company has already received co...
Peer comparison
Common in companies with long-term service contracts or subscription-based diagnostic models; peers with high recurring revenue often show higher balances.
contract_liabilitiesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $87.00M | $85.00M | $79.00M | $117.00M | $98.00M | $85.00M | $102.00M | $93.00M | $103.00M | $68.00M | $109.00M | $84.00M | $76.00M | $68.00M | $58.00M | $56.00M | $58.00M | $56.00M |
| QoQ Change | — | -2.3% | -7.1% | +48.1% | -16.2% | -13.3% | +20.0% | -8.8% | +10.8% | -34.0% | +60.3% | -22.9% | -9.5% | -10.5% | -14.7% | -3.4% | +3.6% | -3.4% |
| YoY Change | — | — | — | — | +12.6% | +0.0% | +29.1% | -20.5% | +5.1% | -20.0% | +6.9% | -9.7% | -26.2% | +0.0% | -46.8% | -33.3% | -23.7% | -17.6% |
Contract Liabilities at Other Companies
Frequently Asked Questions
- What is Gilead Sciences's contract liabilities?
- Gilead Sciences (GILD) reported contract liabilities of $56.00M in Q3 2025.
- How has Gilead Sciences's contract liabilities changed year-over-year?
- Gilead Sciences's contract liabilities decreased by 17.6% year-over-year, from $68.00M to $56.00M.
- What is the long-term trend for Gilead Sciences's contract liabilities?
- Over 4 years (2020 to 2024), Gilead Sciences's contract liabilities has grown at a -12.1% compound annual growth rate (CAGR), from $97.00M to $58.00M.
- What does contract liabilities mean?
- Money received from customers for products or services that have not yet been delivered.